Molecular Diagnostics News on lab-developed tests and emerging diagnostic technologies. Sep 20, 2022 Transcriptomics Plus 'Immune Tolerance' of Normal Tissue Shows Promise in Lung Cancer Prognosis Premium Sep 19, 2022 Naveris Nabs $33.4M Series A Round Expansion to Further Commercialize Virus-Related Cancer Tests Sep 15, 2022 BriaCell, Caris Life Sciences Partner to Bolster New Immunotherapy Development Sep 14, 2022 Biomarker Test Access for Precision Oncology Varies Widely in Europe, ESMO Survey Finds Premium Sep 12, 2022 ESMO Data Sharpens View of How Grail, Exact Sciences Multi-Cancer Early Detection Tests Perform Premium Sep 12, 2022 Relay Therapeutics to Offer $300M in Common Stock; Inks CDx Deal With Foundation Medicine Sep 11, 2022 Repeat Biomarker Testing Informs Next Steps for Treatment-Resistant EGFR-Mutant NSCLC Patients Premium Sep 11, 2022 PD-L1 Test Comparison Finds Varying Ability to ID Bladder Cancer Patients Who Benefit From Tecentriq Sep 8, 2022 Ivy Brain Tumor Center Using Novel Liquid Biopsy Technique to Track Brain Tumor Treatment Resistance Sep 8, 2022 OncXerna Begins Navicixizumab Phase II Basket Trial Sep 7, 2022 Larger Liquid Biopsy Panels Loom, But Patient Benefit Still Uncertain Premium Sep 6, 2022 Freenome Launches Multi-Cancer Detection Study Using Multiomics, Real-World Evidence Sep 1, 2022 SkylineDx Gains CE-IVD Mark for Melanoma Metastasis Risk Assay Aug 31, 2022 Oncocyte Nets $3M VA Contract for DetermaRx Lung Cancer Prognostic Test Aug 30, 2022 Thermo Fisher Scientific Obtains CE-IVD Mark for Targeted NGS Oncology Test, Analysis Software Aug 29, 2022 Genetic Testing Challenges in Oncology: Lynch Syndrome Diagnosis Despite Negative Test Results Aug 29, 2022 Genome Insight, Ajou University Medical Center to Test WGS Use for Routine Cancer Care Aug 26, 2022 Myriad Genetics Gets Expanded Coverage for BRACAnalysis CDx in Japan Aug 25, 2022 VolitionRx Taking on Nucleosome-Focused Dx for Human Cancers After Canine Cancer Screening Test Premium Aug 25, 2022 Oncgnostics Epigenetic Cervical Cancer Test Wins Chinese Regulatory Approval Load More Breaking News FDA Approves Taiho Oncology's Lytgobi for FGFR2-Rearranged Bile Duct Cancer Gladstone Institute Joins With Parker Institute on New Center to Study CRISPR-Based Cell Therapies Meliora Therapeutics Raises $11M in Seed Financing In Brief This Week:Â Verismo Therapeutics, Fore Biotherapeutics, Merck, Caris Life Sciences Tumor-Only Sequencing Found to Overestimate Mutational Burden in Non-European Patients Atara Biotherapeutics to Net $30M From Pierre Fabre for European Tab-Cel Approval What's Popular? In Molecular Diagnostics ESMO Data Sharpens View of How Grail, Exact Sciences Multi-Cancer Early Detection Tests Perform Premium Biomarker Test Access for Precision Oncology Varies Widely in Europe, ESMO Survey Finds Premium Repeat Biomarker Testing Informs Next Steps for Treatment-Resistant EGFR-Mutant NSCLC Patients Premium Sophia Genetics Partners With MSK on Clinical Decision Support, Boundless Bio on ecDNA Detection Transcriptomics Plus 'Immune Tolerance' of Normal Tissue Shows Promise in Lung Cancer Prognosis Premium
